At 8.1% CAGR, Global Basal Cell Carcinoma Treatment Market to Hit USD 12.8 Billion by 2028, Says Zion Market Research | Industry Trends, Share, Growth, Value, Analysis & Forecast Report
22 Jun 2022
ImmunotherapyRadiation TherapySmall molecular drug
NEW YORK, June 22, 2022 /PRNewswire/ -- As per Zion Market Research study,
The global basal cell carcinoma treatment market had total revenues of roughly USD 5.53 billion in 2021 and is predicted to grow to around USD 12.8 billion by 2028, with a CAGR of around 8.1 percent.
Key Industry Insights & Finding of the Basal Cell Carcinoma Treatment Market Reports:
As per the analysis shared by our research analyst, the Basal Cell Carcinoma Treatment Market is expected to grow annually at a CAGR of around
8.1 % (2022-2028).
Through the primary research, it was established that the Basal Cell Carcinoma Treatment Market was valued approximately
USD
5.53 Billion in 2021 and is projected to reach to roughly
USD
12.8 Billion by 2028.
North America is expected to dominate the global basal cell carcinoma treatment market throughout the projected period.
The United States is anticipated to hold the major share owing to the presence of major players, and well-developed healthcare infrastructure. Asia Pacific is expected to grow at a rapid rate during the forecast period.
As botanical drugs were granted FDA approval in 2004, an increasing number of established and developing companies, notably large pharmaceutical companies, have begun to produce plant-derived and botanical drugs.
Zion Market Research published the latest report titled as
"Basal Cell Carcinoma Treatment Market By Treatment Type (Radiation Therapy, Drugs, And Surgery), By End-User (Specialty Clinics, Hospitals, And Others), And By Region – Global And Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts 2022 – 2028." into their research database.
Basal CellBasal Cell Carcinoma Treatment Market : Overview
Basal cell carcinoma is a type of skin cancer that is commonly found in all types of cancers. Basal cell carcinoma is caused by the uncontrolled development of basal cells. Since basal cell carcinoma has a slower growth rate, it is curable and can cause relatively little damage if identified early and treated. The malignancy must be removed in order to treat basal cell carcinoma. Treatment is determined by the location, size, and type of cancer. The type of treatment depends on whether the carcinoma is a newly diagnosed or reoccurring cancer.
Get a Free Sample Report with All Related Graphs & Charts (with COVID 19 Impact Analysis):
https://www.zionmarketresearch.com/sample/basal-cell-carcinoma-treatment-market
Our Free Sample Report Includes:
2022 Updated Report Introduction, Overview, and In-depth industry analysis
COVID-19 Pandemic Outbreak Impact Analysis Included
185 + Pages Research Report (Inclusion of Updated Research)
Provide Chapter-wise guidance on Request
2022 Updated Regional Analysis with Graphical Representation of Size, Share & Trends
Includes Updated List of tables & figures
Updated Report Includes Top Market Players with their Business Strategy, Sales Volume, and Revenue Analysis
Zion Market Research methodology
Basal Cell Carcinoma Treatment Market : Growth Drivers
Increasing prevalence of basal cell carcinoma to drive the market growth.
Skin cancers (the majority of which are basal and squamous cell skin tumors) are the most frequent of all cancers. Each year, roughly 5.4 million squamous and basal cell skin malignancies are detected in the United States, according to one study. Basal cell tumors account for about eight out of ten of these malignancies. For many years, the incidence of these cancers has been rising. This is likely due to a combination of increased sun exposure and improved skin cancer detection. Thus, the rising prevalence of basal cell carcinoma is among the primary factor boosting the growth of the market. In addition to this, developing healthcare infrastructure and growing initiatives for awareness regarding the early diagnosis of diseases are estimated to foster market growth.
Basal Cell Carcinoma Treatment Market : Restraints
High costs related to basal cell carcinoma treatment to hinder the market growth.
The cost for basal cell carcinoma depends on its stage and location. Radiation, chemotherapy, and surgery are some of the treatment options for this cancer. Some expenses are covered by insurance, but out-of-pocket expenses might be hefty. Treatment for all types of skin cancer, according to the CDC, costs approximately $8 billion each year. By 2030, the organization estimates that treating new patients will cost $1.6 billion each year. Many cancer medications, particularly immunotherapy treatments, are quite costly. It is also being observed that persons with metastatic cancer spend more than 6 times more on care in the 12 months after their initial diagnosis than those with localized cancer. Also, one or maybe more chemotherapeutic drugs are frequently used to treat skin cancer. Many are brand-new drugs with a hefty price tag. New cancer treatments, according to the National Cancer InstituteCancer Institute, can cost over $100,000 per patient annually. Thus, such high costs associated with the treatment of basal cell carcinoma are likely to impede the growth of the global basal cell carcinoma treatment market.
Directly Purchase a Copy of the Report @
https://www.zionmarketresearch.com/buynow/su/basal-cell-carcinoma-treatment-market
Global Basal Cell Carcinoma Treatment Market : Opportunities
Heavy investment by major players in the development of drugs and R&D activities to fuel market.
As botanical drugs were granted FDA approval in 2004, an increasing number of established and developing companies, notably large pharmaceutical companies, have begun to produce plant-derived and botanical drugs. As a result, both public and private investment is increasing in this industry. Botanicals are expected to rise rapidly as advances in plant culture technologies improve efficiency and lower development costs. As a result, major medical organizations are expected to increase their investments in basal cell carcinomas drugs & therapies, thereby propelling the global basal cell carcinoma treatment market growth forward during the forecast period.
Global Basal Cell Carcinoma Treatment Market : Challenges
Management of advanced and high-risk basal cell carcinoma is a challenge for the market.
For advanced basal cell carcinoma, Hedgehog inhibitors and surgical treatments, particularly Mohs surgery, have ruled the therapy landscape. However, not every patient is suitable for surgery, and for Hedgehog inhibitors, tolerance and progression difficulties can make long-term disease care difficult. Some BCC patients progress to a stage where they face considerable management issues. Recurring, locally advanced, or metastatic BCC, as well as tumors that exist in anatomical places where surgical treatment would result in substantial deformity, are examples of such situations. Thus, management of advanced BCC coupled with strict regulatory standards for the approval of new drugs acts as major challenge to the growth of the market.
Global Basal Cell Carcinoma Treatment Market : Segmentation
The global basal cell carcinoma treatment market is categorized into treatment type, end-user, and region.
Based on the treatment type, the global market is divided into radiation therapy, drugs, and surgery. The end-user segment consists of specialty clinics, hospitals, and others.
Get More Insight before [email protected] : https://www.zionmarketresearch.com/inquiry/basal-cell-carcinoma-treatment-market
List of Key Players of Basal Cell Carcinoma Treatment Market :
Mylan N.V.
Merck and Co. Inc.
Sanofi
Bausch Health Companies
Key questions answered in this report:
What are the growth rate forecast and market size for Basal Cell Carcinoma Treatment Market ?
What are the key driving factors propelling the Basal Cell Carcinoma Treatment Market forward?
What are the most important companies in the Basal Cell Carcinoma Treatment Market Industry?
What segments does the Basal Cell Carcinoma Treatment Market cover?
How can I receive a free copy of the Basal Cell Carcinoma Treatment Market sample report and company profiles?
Free Brochure: https://www.zionmarketresearch.com/requestbrochure/basal-cell-carcinoma-treatment-market
Recent Developments
In June 2021, Sanofi and Regeneron's PD-1 inhibitorPD-1 inhibitor Libtayo® has received approval from the European Commission to treat people with locally advanced or metastatic basal cell carcinoma who have advanced or are intolerant to a Hedgehog pathway inhibitor.
In June 2020, Provectus unveiled approval from The Indian Patent Office for its patent application for the combination of novel autolytic cancer immunotherapy PV-10® with systemic immunomodulatory therapy, such as immune checkpoint inhibition (CB). PV-10, which is based on small molecules, is injected into superficial melanoma and non-melanoma skin cancer including squamous cell carcinoma, Merkel cell carcinoma, and basal cell carcinoma via cutaneous intratumoral injection.
Regional Dominance:
North America to lead the market during the forecast period.
North America is expected to dominate the global basal cell carcinoma treatment market throughout the projected period. This is attributable to key aspects such as the favorable reimbursement policies, increased awareness of advanced treatments, the growing senior population, and the region's high prevalence of basal cell carcinoma. The United States is anticipated to hold the major share owing to the presence of major players, and well-developed healthcare infrastructure. Asia Pacific is expected to grow at a rapid rate during the forecast period.
Global Basal Cell Carcinoma Treatment Market is segmented as follows:
Basal Cell Carcinoma Treatment Market : By Treatment Type Outlook (2022-2028)
Surgery
Drugs
Basal Cell Carcinoma Treatment Market : By End-Use Outlook (2022-2028)
Hospitals
Others
Basal Cell Carcinoma Treatment Market : By Region Outlook (2022-2028)
North America
The U.S.
Canada
Europe
France
The UK
Spain
Germany
Italy
Rest of Europe
China
Japan
India
South Korea
Southeast Asia
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
GCC
South Africa
Rest of Middle East & Africa
Press Release For Basal Cell Carcinoma Treatment Market :
https://www.zionmarketresearch.com/news/global-basal-cell-carcinoma-treatment-market
Browse Other Related Research Reports from Zion Market Research
Pharmaceutical Sterility Testing Market - Global Industry Analysis
: The global Pharmaceutical Sterility Testing Market accrued earnings worth approximately 1.2(USD Billion) in 2020 and is predicted to gain revenue of about 2.3 (USD Billion) by 2028, is set to record a CAGR of nearly 11.9% over the period from 2021 to 2028.
Medical Enzyme Technology Market - Global Industry Analysis
: The global Medical Enzyme Technology market accrued earnings worth approximately 4.5(USD Billion) in 2020 and is predicted to gain revenue of about 6.7(USD Billion) by 2028, is set to record a CAGR of nearly 6.2% over the period from 2021 to 2028.
Oncolytic Virus Immunotherapy Market - Global Industry Analysis
: The global Oncolytic Virus Immunotherapy market accrued earnings worth approximately301 (USD Million) in 2020 and is predicted to gain revenue of about 678(USD Million) by 2028, is set to record a CAGR of nearly 12.1% over the period from 2021 to 2028.
Browse through Zion Market Research's coverage of the
Follow Us on: LinkedIn | Twitter | Facebook
About Us
Zion Market Research is an obligated company. We create futuristic, cutting edge, informative reports ranging from industry reports, company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client's needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us
.
Contact Us:
Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651
Email: [email protected]
Website: https://www.zionmarketresearch.com/
Blog : https://zmrblog.com/ | Market Business Insights
Logo: https://mma.prnewswire.com/media/1605489/Zion_Market_Research_Logo.jpg
SOURCE Zion Market Research
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
Chat with Hiro
Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.